Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase

NCT00520260 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Dry Eye Disease
Ocular Comfort

Interventions

DRUG: bromfenac
DRUG: ketorolac

Sponsor

Florida Eye Microsurgical Institute

Collaborators

[object Object]